Einstein/Montefiore Department of Medicine

In The Media

Wall Street Journal interviews Judy Wylie-Rosett, Ph.D., about research that suggests artificial sweeteners may raise blood sugar levels by altering the body’s gut bacteria. Dr. Wylie-Rosett notes that the study is important since it is the first to examine how gut microbes contribute to processing real and fake sugars. Dr. Wylie-Rosett is head of the division of health promotion and nutrition research, and professor of epidemiology & population health and of medicine at Einstein.

(Thursday, September 18, 2014)

Dr. Rosett's Profile
 
 

The Washington Post reports on research by Joe Verghese, M.B.B.S., that predicts pre-dementia by measuring walking speed and cognitive abilities. The quick, low-tech test determined that 1 in 10 older adults have pre-dementia. The study involved 27,000 people in 7 countries. It found that those who had unusually slow walking speed and cognitive complaints are twice as likely to develop dementia within 12 years. Dr. Verghese is professor of neurology at Einstein and chief of the division of geriatrics at Einstein and Montefiore Medical Center.

(Tuesday, August 05, 2014)

Dr. Verghese's Profile
 
 

The New York Times Magazine quotes Paul Frenette, M.D., in an article on research linking the nervous system to inflammation. Dr. Frenette has discovered that nerves play a key role in triggering prostate cancer, which is also associated with inflammation. Dr. Frenette is professor of medicine and of cell biology and director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research.

(Tuesday, May 27, 2014)

Dr. Frenette's Profile
 
 

NPR interviews Arturo Casadevall, M.D., Ph.D., about balancing scientific openness with potential security risks in light of research that omitted key details about the deadly Botulism toxin. Dr. Casadevall noted there needs to be a standard for handling such difficult situations and is calling for the creation of a national board to recommend what information should be kept secret. Dr. Casadevall is professor and chair of microbiology & immunology and the Leo and Julia Forchheimer Chair in Microbiology & Immunology at Einstein.

(Thursday, April 24, 2014)

Dr. Casadevall's Profile
 
 

The Washington Post interviews Brian Currie, M.D., M.P.H., about a new medical research data-sharing network to house the records of nearly 30 million Americans. The Patient-Centered Outcomes Research Institute’s network will make it easier to identify patients who could be invited to join clinical trials and conduct comparative effectiveness and clinical outcomes research. Dr. Currie is professor of clinical medicine and of clinical epidemiology & population health at Einstein and assistant dean for clinical research at Montefiore Medical Center.

(Friday, April 18, 2014)

Dr. Currie's Profile
 
 

The Atlantic features research by Arturo Casadevall, M.D., Ph.D., that suggests an easy way to help increase the number of female speakers at conferences. Dr. Casadevall’s study found having at least one woman on the organizing committee of a meeting increased the proportion of female speakers by 72 percent compared with those convened by men alone. Dr. Casadevall is professor and chair of microbiology & immunology and the Leo and Julia Forchheimer Chair in Microbiology & Immunology and director of the Center for Immunological Sciences at Einstein.

(Tuesday, January 07, 2014)

Dr. Casadevall's Profile
 
 

WNYC Radio interviews Edward Burns, M.D., about the planned budget deal could restore some funding to the National Institutes of Health. Dr. Burns notes that the sequester – which cut budgets between five to ten percent – was deadly for research and might even stop young scientists from pursuing a research career. Dr. Burns is executive dean and professor of pathology and of medicine. (Audio begins at 1:32)

(Thursday, December 19, 2013)

Dr. Burns' Profile
 
 

BBC News interviews Harry Ostrer, M.D., and The New York Times cites research by Gil Atzmon, Ph.D., in two articles about a new study on Jewish genetic history. The new study analyzed mitochondrial DNA, genetic information inherited through women, and found that at least 80 percent of Ashkenazi maternal ancestry hailed from Europe, not the Middle East, suggesting that many European Jewish communities were founded by men who married and converted local women. Dr. Ostrer is professor of pathology, of genetics and of pediatrics at Einstein and director of genetic and genomic testing at Montefiore Medical Center. Dr. Atzmon is associate professor of medicine and of genetics.

(Wednesday, October 09, 2013)

Dr. Ostrer's Profile | Dr. Atzmon's Profile
 
 

CBSNews.com interviews Lou Weiss, M.D., M.P.H., about a new blood test that determines whether a person's respiratory illness is caused by virus or bacteria. Dr. Weiss explains that the test, which provides results in only 12 hours, has the potential to be extremely beneficial because it can help with diagnosis and prevent doctors from giving unnecessary antibiotics, which drives the growing problem of antibiotic resistance. Dr. Weiss is professor of pathology and of medicine at Einstein.

(Tuesday, September 24, 2013)

Dr. Weiss' Profile
 
 

NPR interviews Nir Barzilai, M.D., about a new study that showed men who adopted healthier lifestyles had longer telomeres. Telomeres protect the tips of chromosomes and are associated with lower risk for many chronic diseases and longer lifespan. Dr. Barzilai notes that the study doesn't answer the fundamental question of causation — whether someone is healthy because they have longer telomeres or someone's telomeres become longer because they are healthy. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of Einstein's Institute for Aging Research.

(Tuesday, September 17, 2013)

Dr. Barzilai's Profile
 
 

Methamphetamine users are more vulnerable to fungal lung infections according to new research by Luis Martinez, Ph.D., featured in The Los Angeles Times. Dr. Martinez and his colleagues found that the illicit drug weakened the blood-brain barrier, which facilitated cryptococcosis fungal infection and accelerated the progression of disease in mice. Dr. Martinez is adjunct clinical assistant professor of medicine at Einstein.

(Thursday, August 01, 2013)

Dr. Martinez's Profile
 
 

The Hill published an op-ed by Einstein's Dean, Allen M. Spiegel, M.D., and Montefiore President and CEO Steven Safyer, M.D., titled "Angelina Jolie, the Sequester, and Health in America." The authors argue that Ms. Jolie's decision to undergo a prophylactic mastectomy was made possible by two decades of research by inquisitive scientists on the BRCA1 and BRCA2 genes, much of it supported by the NIH. They assert that the funding cuts demanded by the sequester places this type of research in jeopardy.

(Tuesday, June 25, 2013)

Dr. Spiegel's Profile | Dr. Safyer's Profile
 
 

Forbes interviews Jill Crandall, M.D., about resveratrol, an extract of red wine, and its potential to boost metabolism in humans. Dr. Crandall, who studies resveratrol’s effect on insulin sensitivity, notes that the research in humans is still too early and does not provide enough evidence to suggest that people take supplements. Dr. Crandall is associate professor of clinical medicine at Einstein and attending physician of endocrinology at Montefiore Medical Center.

(Tuesday, June 25, 2013)

Dr. Crandall's Profile
 
 

Medscape interviews Dr. Elizabeth Walker about her research that found targeted phone calls may help control diabetes in poor, underserved urban areas. The phone calls, which were made by health educators from the same community as the participants, provided counseling for medication adherence, exercise and diet. Dr. Walker is professor of medicine and epidemiology & population health. Dr. Walker is professor of medicine and epidemiology & population health. (Login required)

(Tuesday, June 25, 2013)

Dr. Walker's Profile
 
 

Geoffrey Kabat, Ph.D., interviews Nir Barzilai, M.D., in a Forbes article about his aging research and the genetic determinants of healthy longevity. Dr. Kabat reports that Dr. Barzilai’s lab has discovered several genetic variants that appear to extend human health-span, one of which is the basis of a drug currently in phase III clinical trials. Dr. Kabat is a senior epidemiologist at Einstein. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of Einstein’s Institute for Aging Research.

(Thursday, May 30, 2013)

Dr. Barzilai's Profile
 
 
First Page | Previous Page | Page of 9 | Next Page | Last Page
Click here to log in